Redalpine Venture Partners has supported a second funding round for its portfolio company Lunaphore, a Swiss medical device developer based in Lausanne.
Mercia invests directly from its balance sheet after previously using third party funds
Fresh capital will be used to expand globally and facilitate cross-carrier collaboration
Through the transaction, the GP will offer financial and management resources to the firm
Buyout of Baywater Healthcare was Duke Street's second deal-by-deal financing